The prospective of the biotechnology industry on changing technology in pathology.
Recent rapid developments in biotechnology are causing both an evolution and a revolution in science, medicine, and society. A number of potentially useful therapeutic products, diagnostics, blood products, and vaccines have been and will be developed that will represent great advances to the practicing physician and laboratory diagnostician. A large new industry is resulting and with this new science, new social and ethical issues are being raised, such as in regard to gene therapy, and will be debated for some years to come. As knowledge of the human genome increases, and further insights into the structure of receptors and the cell are obtained, even more useful products and technologies will emerge and change our lives over the next 20 years.
D000911:Antibodies, Monoclonal; D001709:Biotechnology; D001769:Blood; D019411:Clinical Laboratory Techniques; D005818:Genetic Engineering; D006801:Humans; D007883:Legislation, Medical; D008222:Lymphokines / Q000627:therapeutic use; D009693:Nucleic Acid Hybridization; D010336:Pathology; D014481:United States; D014612:Vaccines
D000911:Antibodies, Monoclonal; D008222:Lymphokines; D014612:Vaccines